Lim Jeewon, Hwang Yo Sep, Yoon Hyang Ran, Yoo Jiyun, Yoon Suk Ran, Jung Haiyoung, Cho Hee Jun, Lee Hee Gu
Immunotherapy Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, 34141, Republic of Korea.
Department of Biomolecular Science, University of Science and Technology (UST), Daejeon, 34113, Republic of Korea.
Cancer Cell Int. 2024 Feb 14;24(1):73. doi: 10.1186/s12935-024-03254-z.
Rho guanine nucleotide dissociation inhibitor 1 (RhoGDI1) plays an important role in diverse cellular processes by regulating Rho guanosine triphosphate (GTP)ases activity. RhoGDI1 phosphorylation regulates the spatiotemporal activation of Rho GTPases during cell migration. In this study, we identified polo-like kinase 1 (PLK1) as a novel kinase of RhoGDI1 and investigated the molecular mechanism by which the interaction between RhoGDI1 and PLK1 regulates cancer cell migration.
Immunoprecipitation, GST pull-down assay, and proximity ligation assay (PLA) were performed to analyze the interaction between RhoGDI1 and PLK1. In vitro kinase assay and immunoprecipitation were performed with Phospho-(Ser/Thr) antibody. We evaluated RhoA activation using RhoGTPases activity assay. Cell migration and invasion were analyzed by transwell assays.
GST pull-down assays and PLA showed that PLK1 directly interacted with RhoGDI1 in vitro and in vivo. Truncation mutagenesis revealed that aa 90-111 of RhoGDI1 are critical for interacting with PLK1. We also showed that PLK1 phosphorylated RhoGDI1 at Thr7 and Thr91, which induces cell motility. Overexpression of the GFP-tagged RhoGDI1 truncated mutant (aa 90-111) inhibited the interaction of PLK1 with RhoGDI1 and attenuated RhoA activation by PLK1. Furthermore, the overexpression of the RhoGDI1 truncated mutant reduced cancer cell migration and invasion in vitro and suppressed lung metastasis in vivo.
Collectively, we demonstrate that the phosphorylation of RhoGDI1 by PLK1 promotes cancer cell migration and invasion through RhoA activation. This study connects the interaction between PLK1 and RhoGDI1 to the promotion of cancer cell behavior associated with malignant progression, thereby providing opportunities for cancer therapeutic interventions.
Rho鸟嘌呤核苷酸解离抑制剂1(RhoGDI1)通过调节Rho鸟苷三磷酸(GTP)酶活性在多种细胞过程中发挥重要作用。RhoGDI1磷酸化在细胞迁移过程中调节Rho GTP酶的时空激活。在本研究中,我们确定polo样激酶1(PLK1)是RhoGDI1的一种新型激酶,并研究了RhoGDI1与PLK1之间的相互作用调节癌细胞迁移的分子机制。
进行免疫沉淀、GST下拉分析和邻近连接分析(PLA)以分析RhoGDI1与PLK1之间的相互作用。用磷酸化(丝氨酸/苏氨酸)抗体进行体外激酶分析和免疫沉淀。我们使用RhoGTP酶活性分析评估RhoA激活。通过Transwell分析分析细胞迁移和侵袭。
GST下拉分析和PLA表明PLK1在体外和体内直接与RhoGDI1相互作用。截短诱变显示RhoGDI1的第90 - 111位氨基酸对于与PLK1相互作用至关重要。我们还表明PLK1在苏氨酸7和苏氨酸91处磷酸化RhoGDI1,从而诱导细胞运动性。绿色荧光蛋白标记的RhoGDI1截短突变体(第90 - 111位氨基酸)的过表达抑制了PLK1与RhoGDI1的相互作用,并减弱了PLK1对RhoA的激活。此外,RhoGDI1截短突变体的过表达降低了体外癌细胞的迁移和侵袭,并抑制了体内肺转移。
总体而言,我们证明PLK1介导的RhoGDI1磷酸化通过RhoA激活促进癌细胞迁移和侵袭。本研究将PLK1与RhoGDI1之间的相互作用与促进与恶性进展相关的癌细胞行为联系起来,从而为癌症治疗干预提供了机会。